dihydroisotanshinone i has been researched along with Cancer of Cervix in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Wang, C; Xu, W; Ye, Y; Zhong, W | 1 |
1 other study(ies) available for dihydroisotanshinone i and Cancer of Cervix
Article | Year |
---|---|
Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Chemoradiotherapy; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Female; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Gamma Rays; HeLa Cells; Humans; Mice; Mice, Nude; Oncogene Proteins, Viral; Papillomaviridae; Phenanthrenes; Time Factors; Tumor Burden; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2012 |